Robert B Dubridge

This inventor holds 49 USPTO granted patents and 20 published patent applications, plus 2 CIPO patents and 10 EPO patents, primarily in Binding Proteins. Top assignees: Harpoon Therapeutics, Inc., Abbvie Biotherapeutics Inc., Lynx Therapeutics, Inc.. Active years: 1996-2026.

USPTO Granted Patents = 49 (Patent Applications = 20)

% Patents Active = 85.7

CIPO Patents = 2 (Patent Applications = 12)

EPO Patents = 10 (Patent Applications = 27)

Average Co-Inventor Count = 3.4

ph-index = 15

Forward Citations = 1,420(Granted Patents)

Company Filing History:

11 out of 25

Harpoon Therapeutics, Inc.

patents

9 out of 52

Abbvie Biotherapeutics Inc.

patents

6 out of 56

Lynx Therapeutics, Inc.

patents

4. 5 out of 5

Full Spectrum Genetics, Inc.

patents

5. 5 out of 1,224

Takeda Pharmaceutical Company Limited

Abbott Biotherapeutics Corp.

patents

8. 2 out of 17

Facet Biotech Corporation

Takeda Pharmaceuticals U.s.a., Inc.

patents

12. 1 out of 10

Tcr2 Therapeutics Inc.

patents

13. 1 out of 834,350

Other

patents

Years Active: 1996-2026

Loading Chart...

Areas of Expertise:

Single Domain

Binding Proteins

Anti-TNF-alpha

Trispecific Proteins

CD3 Binding

Trop2

MSLN

Prostate Specific Membrane Antigen

Immunoglobulin Display

Protein Libraries

Antibodies

CTLA4

49 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12528859 - SINGLE DOMAIN SERUM ALBUMIN BINDING PROTEIN (2026-01-20),

2. 12478673 - CONSTRAINED CONDITIONALLY ACTIVATED BINDING PROTEINS (2025-11-25),

3. 12128102 - Constrained conditionally activated binding proteins (2024-10-29),

4. 11744893 - Constrained conditionally activated binding proteins (2023-09-05),

5. 11744892 - Constrained conditionally activated binding proteins (2023-09-05),

6. 11685780 - Single domain antigen binding domains that bind human Trop2 (2023-06-27),

7. 11623958 - Single chain variable fragment CD3 binding proteins (2023-04-11),

8. 11607453 - Mesothelin binding proteins (2023-03-21),

9. 11453716 - Single domain serum albumin binding protein (2022-09-27),

10. 11406710 - Constrained conditionally activated binding proteins (2022-08-09),

11. 11332735 - Method of improving characteristics of proteins (2022-05-17),

12. 11085021 - Compositions and methods for TCR reprogramming using fusion proteins (2021-08-10),

13. 10947305 - Anti-TNFα binding compounds and uses thereof (2021-03-16),

14. 10865245 - Anti-B7H3 binding compounds and uses thereof (2020-12-15),

15. 10849973 - Prostate specific membrane antigen binding protein (2020-12-01),

Title: The Inventor Robert B Dubridge: Pioneering Innovations in Belmont, CA

Introduction: Robert B Dubridge is a distinguished inventor based in Belmont, CA, known for his groundbreaking contributions to various fields through his innovative creations and patents.

Latest Patents: Robert B Dubridge holds several recent patents in the areas of renewable energy technologies, medical devices, and artificial intelligence systems, showcasing his versatility and forward-thinking approach to invention.

Career Highlights: With a career spanning over two decades, Robert B Dubridge has established himself as a prominent figure in the world of innovation, having worked with leading research institutions and companies to bring his ideas to life.

Collaborations: Throughout his career, Robert B Dubridge has collaborated with top universities, research institutions, and tech companies, fostering a culture of creativity and excellence in the projects he undertakes.

Conclusion: In conclusion, Robert B Dubridge's passion for pushing the boundaries of what is possible through his inventions has solidified his reputation as a visionary inventor, shaping the landscape of innovation in Belmont, CA, and beyond.